V023-8827 Screening compound: N~1~-[11-(4-isopropylpiperazino)dibenzo[b,f][1,4]oxazepin-2-yl]-1-cyclopentanecarboxamide

V023-8827 Screening compound: N~1~-[11-(4-isopropylpiperazino)dibenzo[b,f][1,4]oxazepin-2-yl]-1-cyclopentanecarboxamide
V023-8827 Screening compound: N~1~-[11-(4-isopropylpiperazino)dibenzo[b,f][1,4]oxazepin-2-yl]-1-cyclopentanecarboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V023-8827
N~1~-[11-(4-isopropylpiperazino)dibenzo[b,f][1,4]oxazepin-2-yl]-1-cyclopentanecarboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V023-8827

Molecular Formula

C26H32N4O2 (C26 H32 N4 O2)

Compound Name

N~1~-[11-(4-isopropylpiperazino)dibenzo[b,f][1,4]oxazepin-2-yl]-1-cyclopentanecarboxamide

IUPAC name

N-{10-[4-(propan-2-yl)piperazin-1-yl]-2-oxa-9-azatricyclo[9.4.0.0^{38}]pentadeca-1(11)35791214-heptaen-13-yl}cyclopentanecarboxamide

SMILES

CC(C)N(CC1)CCN1C1=Nc(cccc2)c2Oc(cc2)c1cc2NC(C1CCCC1)=O

InChI

InChI=1S/C26H32N4O2/c1-18(2)29-13-15-30(16-14-29)25-21-17-20(27-26(31)19-7-3-4-8-19)11-12-23(21)32-24-10-6-5-9-22(24)28-25/h5-6,9-12,17-19H,3-4,7-8,13-16H2,1-2H3,(H,27,31)

InChI Key

UJPHUONTPDSKLV-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14265789

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

432.57

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

4.394

Distribution Coefficient, logD

3.680

Water Solubility, LogSw

-4.30

Polar Surface Area

45.775

Acid Dissociation Constant (pKa)

13.50

Base Dissociation Constant (pKb)

8.02

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

46.20

V023-8827 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CNS BBB Library (22607 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Nervous system
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
Targets:
  • Kinases
  • Others
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with V023-8827 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V023-8827?
Check Price and Availability of V023-8827, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V023-8827 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V023-8827
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V023-8827
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V023-8827 available by request